Tiny swimming bio-bots boldly go where no bot has swum before
The alien world of aquatic microorganisms just got new residents: synthetic self-propelled swimming bio-bots.
A team of engineers has developed a class of tiny bio-hybrid machines that swim like sperm, the first synthetic structures that can traverse the viscous fluids of biological environments on their own. Led by Taher Saif, the Univ. of Illinois Gutgsell prof. of mechanical science and engineering, the team published its work in Nature Communications.
“Microorganisms have a whole world that we only glimpse through the microscope,” Saif said. “This is the first time that an engineered system has reached this underworld.”
The bio-bots are modeled after single-celled creatures with long tails called flagella. The researchers begin by creating the body of the bio-bot from a flexible polymer. Then they culture heart cells near the junction of the head and the tail. The cells self-align and synchronize to beat together, sending a wave down the tail that propels the bio-bot forward.
This self-organization is a remarkable emergent phenomenon, Saif said, and how the cells communicate with each other on the flexible polymer tail is yet to be fully understood. But the cells must beat together, in the right direction, for the tail to move.
“It’s the minimal amount of engineering—just a head and a wire,” Saif said. “Then the cells come in, interact with the structure, and make it functional.”
The team also built two-tailed bots, which they found can swim even faster. Multiple tails also opens up the possibility of navigation. The researchers envision future bots that could sense chemicals or light and navigate toward a target for medical or environmental applications.
“The long-term vision is simple,” said Saif, who is also part of the Beckman Institute for Advanced Science and Technology at the Univ. of Illinois. “Could we make elementary structures and seed them with stem cells that would differentiate into smart structures to deliver drugs, perform minimally invasive surgery or target cancer?”